Hyperlipasemia and Potential Pancreatic Injury Patterns in COVID-19: A Marker of Severity or Innocent Bystander?

Gastroenterology. 2021 Feb;160(3):946-948.e2. doi: 10.1053/j.gastro.2020.10.037. Epub 2020 Oct 28.
No abstract available

Keywords: COVID-19; Clinical Outcome; Hyperlipasemia; Lipase; Pancreatitis; SARS-CoV-2; Severity.

Publication types

  • Systematic Review

MeSH terms

  • Biomarkers / blood
  • COVID-19 / diagnosis
  • COVID-19 / epidemiology*
  • Clinical Enzyme Tests
  • Humans
  • Lipase / blood*
  • Pancreatic Diseases / blood
  • Pancreatic Diseases / diagnosis
  • Pancreatic Diseases / epidemiology*
  • Predictive Value of Tests
  • Prevalence
  • Prognosis
  • Risk Assessment
  • Risk Factors
  • Severity of Illness Index
  • Up-Regulation

Substances

  • Biomarkers
  • Lipase
  • PNLIP protein, human